Αρχική World News No Survival Benefit from Adding Adjuvant Chemotherapy to Endocrine Therapy in Older... World News No Survival Benefit from Adding Adjuvant Chemotherapy to Endocrine Therapy in Older Women with a Genomic Grade Index High-Risk ER-positive, HER2-negative Breast Cancer Από Ogkologos - 19 Αυγούστου, 2025 785 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ASTER 70s study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Could virtual reality become a reality in cancer supportive care? EMA recommends granting a marketing authorisation for daraxonrasib Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? MOST POPULAR Unusual or Nonreportable Results from Prenatal cfDNA-Sequencing Suggestive for an Occult... 13 Δεκεμβρίου, 2024 Breast Cancer Survivor Opens Her Own Business 17 Years After Beating... 25 Φεβρουαρίου, 2021 Patient Guide on Cancer Pain Management Now Available Also in French 16 Δεκεμβρίου, 2025 Cancer in My Community: Working Toward Early Diagnosis for Children With... 3 Αυγούστου, 2023 Φόρτωση περισσοτέρων HOT NEWS Making Cancer Clinical Trials Available to More Patients Woman Diagnosed with Breast Cancer at 33 Launches Self-Examination App Fruquintinib Prolongs Survival Compared with Placebo in Heavily Pretreated Patients with... Dwayne Johnson Sends Special “Moana” Message To 3-Yr-Old Battling Cancer.